PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsOptive
Optive
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
63 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Dry eye syndromesD015352—H04.12215212553
Keratoconjunctivitis siccaD007638EFO_1000906—214101228
Eye diseasesD005128EFO_0003966H441—2148
SyndromeD013577—————134
CataractD002386EFO_0001059H26.9———2—2
KeratoconjunctivitisD007637—H16.2———2—2
Prostatic neoplasmsD011471—C61———1—1
Ocular hypertensionD009798EFO_1001069H40.0———1—1
Open-angle glaucomaD005902EFO_0004190H40.1———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Refractive errorsD012030HP_0000483H52.7—11—12
ConjunctivitisD003231—H10—11——1
Viral conjunctivitisD003236EFO_0008571B30—11——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Fuchs' endothelial dystrophyD005642EFO_0003946H18.51—2———2
Corneal endothelial cell lossD055954———1———1
Hereditary corneal dystrophiesD003317—H18.5—1———1
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Retinal diseasesD012164—H35.9————11
Retinal artery occlusionD015356EFO_1001154H34.1————11
Macular degenerationD008268EFO_0001365H35.30————11
Diabetic retinopathyD003930EFO_0003770—————11
MyopiaD009216EFO_0003927H52.1————11
Degenerative myopiaD047728—H44.2————11
Sjogren's syndromeD012859EFO_0000699M35.0————11
Meibomian gland dysfunctionD000080343—H02.88————11
HypersensitivityD006967EFO_0003785T78.40————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,985 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use